Breathgreen Pharmaceutical is an API manufacturer based in China. It holds 13 active US drug master files and 5 valid CEPs across a filed portfolio of 10 molecules.
| Site | FDA FEI |
|---|---|
| Zaozhuang City, China | Not on file |
| Zaozhuang, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Mometasone Furoate | EDQM, US FDA | 4 |
| Fluticasone Propionate | EDQM, US FDA | 3 |
| Budesonide | US FDA | 2 |
| Indacaterol | US FDA | 2 |
| Olodaterol | US FDA | 2 |
| Ensifentrine | US FDA | 1 |
| Fluticasone Furoate | US FDA | 1 |
| Glycopyrronium | US FDA | 1 |
| Tiotropium | US FDA | 1 |
| Tiotropium Bromide Monohydrate | EDQM | 1 |
Also appears on these molecule pages
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Breathgreen Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.